Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS)

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 11, 2022

Primary Completion Date

January 10, 2025

Study Completion Date

January 10, 2025

Conditions
Acute Decompensated Heart Failure
Interventions
DEVICE

Reprieve Decongestion Management System

The Reprieve Decongestion Management System, or Reprieve DMS, is a hospital bedside fluid management console designed to provide personalized and automated infusion of the IV diuretic furosemide and physiological saline in response to the patient's real-time urine output to safely and rapidly decongest patients suffering from Acute Decompensated Heart Failure.

DRUG

Diuretic

Best practices of optimal diuretic dosing such as those demonstrated in recent randomized trials (DOSE, ADVOR, CLOROTIC).

Trial Locations (16)

20010

MedStar Washington Hospital Center, Washington D.C.

27157

Atrium Health Wake Forest Baptist Medical Center, Winston-Salem

27401

Cone Health, Greensboro

27710

Duke University Hospital, Durham

29203

Prisma Health, Columbia

29425

Medical University of South Carolina, Charleston

36532

Eastern Shore Research Institute, Fairhope

43210

Ohio State University Hospital, Columbus

45219

The Lindner Research Center at Christ Hospital, Cincinnati

48197

Trinity Health Ann Arbor Hospital, Ypsilanti

63130

St. Louis VA, St Louis

Washington University, St Louis

75246

Baylor Scott & White, Dallas

78705

Ascension Texas Cardiovascular, Austin

92697

University of California Irvine, Irvine

05401

University of Vermont Medical Center, Burlington

All Listed Sponsors
lead

Reprieve Cardiovascular, Inc

INDUSTRY